Intracellular transducing mechanisms coupled to brain somatostatin receptors

Pharmacological Research

Volumn 33, Issue 6, 1996, Pages 297-305

  Florio, Tullio ^a   Thellung, Stefano ^a   Schettini, Gennaro ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b CENTRO DI BIOTECNOLOGIE AVANZATE   (Italy)

Author keywords

G proteins; Intracellular signalling; Somatostatin receptors

Indexed keywords

BRAIN RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; SOMATOSTATIN RECEPTOR;

ARTICLE; MOLECULAR CLONING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

EID: 0030174997     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1996.0042     Document Type: Article

References (94)

1. 1. Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J, Guillemin R. Hypothalamic peptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 1973; 179: 77-9.
2. 2. Pradayrol L, Lornvall H, Mutt V, Robet A. N-terminally extended somatostatin: the primary structure of somatostatin 28. FEBS Lett 1980; 109: 55-8.
3. 3. Goodman RH, Aron DC, Roos BA. Rat preprosomatostatin. J Biol Chem 1983; 258: 5570-3.
4. 4. Loh YP, Gainer H. Biosynthesis and processing of neuropeptides. In: Krieger DT, Brownstein NJ and Martin JB eds. Brain Peptides. New York: J. Wiley, 1983: 79-116.
5. 5. Brakch N, Cohen P, Boileau G. Processing of human prosomatostatin in AtT20 cell: S-28 S-14 are generated in different secretory pathways. Biochem Biophys Res Commun 1994; 205: 221-9.
6. 6. Reichlin S. Somatostatin. New Engl J Med 1983; 309: 1495-501.
7. 7. Reichlin S. Somatostatin. New Engl J Med 1983; 309: 1556-63.
8. 8. Schettini G. Brain somatostatin: receptor-coupled transducing mechanisms and role in cognitive functions. Pharmacol Res 1991; 23: 203-15.
9. 9. Gray DB, Zelazny D, Manthay D, Pilar G. Endogenous modulation of Ach release by somatostatin and differential role of calcium channels. J Neurosci 1990; 10: 2687-98.
10. 10. Thal LJ, Laing K, Horowitz SG, Makman MH. Dopamine stimulates rat cortical somatostatin release. Brain Res 1986; 372: 205-9.
11. 11. Davies P, Katzman R, Terry RD. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer senile dementia. Nature 1980; 288: 279-80.
12. 12. Atack JR, Beal MF, May C, Kaye JA, Mazurek MF, Kay AD, Rapoport SI. Cerebrospinal fluid somatostatin and neuropeptide Y concentrations in aging and dementia of the Alzheimer's type with and without extrapyramidal signs. Arch Neurol 1988; 45: 269-74.
13. 13. Morrison JH, Rogers J, Scherr S, Benoit R, Bloom FE. Somatostatin immunoreactivity in neuritic plaques of Alzheimer's patients. Nature 1985; 314: 90-2.
14. 14. Roberts JV, Crow TJ, Polak MJ. Location of neuronal tangles in somatostatin neurons in Alzheimer's disease. Nature 1985; 314: 92-4.
15. 15. Tamminga TA, Foster NL, Fedio P, Bird ED, Chase TN. Alzheimer's disease: low cerebral somatostatin levels correlate with impaired cognitive functions and cortical metabolism. Neurology 1987; 37: 161-5.
16. 16. Florio T, Ventra C, Postiglione A, Schettini G. Age-related alterations of somatostatin gene expression in different rat brain areas. Brain Res 1991; 557: 64-8.
17. 17. Vecsei L, Kiraly C, Bollok I, Nagy J, Varga B, Penke B, Telegdy G. Comparative studies into somatostatin and cysteamine in different behavioral tests on rats. Pharmacol Biochem Behav 1984; 21: 833-9.
18. 18. Schettini G, Florio T, Magri G, Grimaldi M, Meucci O, Landolfi E, Marino A. Somatostatin and SMS 201-995 reverse the impairment of cognitive functions induced by cystamine depletion of brain somatostatin. Eur J Pharmacol 1988; 151: 399-407.
19. 19. Florio T, Magri G, Landolfi E, Meucci O, Grimaldi M, Schettini G, Marino A. Depletion of brain somatostatin by cysteamine induces impairment of cognitive functions in rat: reversal by exogenous administration of SRIF or its analogue SMS 201-995. Pharmacol Res Commun 1988; 20: 241-2.
20. 20. Fitzgerald L, Dokla C. Morris water test impairment and hypoactivity following cysteamine-induced reductions of somatostatin-like immunoreactivity. Brain Res 1989; 505: 246-50.
21. 21. Sessions G, Demetriades E, Leber L, Koob G. Cysteamine-induced somatostatin depletion and working memory deficits in rat. 15th Soc Neurosci Meet 1989; abs. 288.5.
22. 22. Koerker D, Ruch W, Chickadel E, Palmer J, Goodner C, Ensink J, Gale C. Somatostatin: hypothalamic inhibitor of the endocrine pancreas. Science 1974; 184: 482-4.
23. 23. Schally AV. Oncological applications of somatostatin analogues. Cancer Res 1988; 48: 6977-85.
24. 24. Reubi J-C, Laissue JA. Multiple actions of somatostatin in neoplastic disease. Trends Pharmacol Sci 1995; 16: 110-5.
25. 25. Yamada Y, Post SR, Wang K, Tager HS, Bell GI, Seino S. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract and kidney. Proc Natl Acad Sci USA 1992; 89: 251-5.
26. 26. Yasuda K, Rens Domiano S, Breder CD, Law S, Saper CB, Reisine T, Bell GI. Cloning of a novel somatostatin receptor SSTR3, coupled to adenylyl cyclase. J Biol Chem 1992; 267: 20422-8.
27. 27. Bruno JF, Xu Y, Song J, Berelowitz M. Molecular cloning and functional expression of a brain specific somatostatin receptor. Proc Natl Acad Sci USA 1992; 89: 11151-5.
28. 28. O'Carroll M, Lolait SJ, Konig M, Mahan LC. Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatin 28. Mol Pharmacol 1992; 42: 939-46.
29. 29. Johnson GL, Danasekaran N. The G-protein family and their interaction with receptors. Endocrine Rev 1989; 10: 317-31.
30. 30. Bell G, Reisine T. Molecular biology of the somatostatin receptors. Trends Neurosci 1993; 16: 34-8.
31. 31. Yamada Y, Kagimoto S, Kubota A, Yasuda K, Massuda K, Someya Y, Ihara Y, Li Q, Imura H, Seino S, Seino Y. Cloning, functional expression and pharmacological characterization of a fourth (hSSTR4) and a fifth (hSSTR5) human somatostatin receptor subtype. Biochem Biophys Res Commun 1993; 195: 844-52.
32. 32. Yamada Y, Stoffel I, Espinosa R, Xiang KS, Seino M, Seino S, LeBeau MM, Bell G. Human somatostatin receptor genes: localization to human chromosome 14, 17 and 22 and identification of simple tandem repeat polymorphism. Genomics 1993; 15: 449-52.
33. 33. Demchyshyn P, Srikant CB, Sunahara RK, Kent G, Seeman P, van Tol HHM, Patel YC, Niznuk HB. Cloning and expression of a human somatostatin receptor variant (SSTR4) located on chromosome 20. Mol Pharmacol 1993; 43: 894-901.
34. 34. Panetta R, Greenwood MT, Warszynska A, Demchyshyn LL, Day R, Nizinik HB, Srikant CB, Patel YC. Molecular cloning, functional characterization and chromosomal localization of a human somatostatin receptor (SSTR5) with preferential affinity for somatostatin 28. Mol Pharmacol 1994; 45: 417-27.
35. 35. Reisine T, Bell G. Molecular biology of somatostatin receptors. Endocrine Rev 1995; 16: 427-42.
36. 36. Patel Y, Srikant C. Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr1-5). Endocrinology 1994; 135: 2814-7.
37. 37. Florio T, Rim C, Hershberger RE, Loda M, Stork PJS. The somatostatin receptor SSTR1 is coupled to phosphotyrosine phosphatase activity in CHOk1 cells. Mol Endocrinol 1994; 8: 1289-97.
38. 38. Florio T, Scorziello A, Fattore M, D'Alto V, Salzano S, Rossi G, Berlingieri MT, Fusco A, Schettini G. Somatostatin inhibits PC C13 thyroid clonal cell line proliferation through the modulation of phosphotyrosine phosphatase activity: impairment of the somatostatinergic effects by stable expression of E1A viral oncogene. J Biol Chem 1996; 271: 6129-36.
39. 39. Patel YC, Panetta R, Escher E, Greenwood M, Srikant CB. Expression of multiple somatostatin receptor genes in AtT20 cells: evidence for a novel somatostatin 28 selective receptor subtype. J Biol Chem 1994; 269: 1506-9.
40. 40. Vanetti M, Kouba M, Wang X, Vogt G, Hollt V. Cloning and expression of a novel mouse somatostatin receptor (SSTR2B). FEBS Lett 1992; 311: 290-4.
41. 41. Bruno JF, Xu Y, Song J, Berelowitz M. Tissue distribution of somatostatin receptor subtype messenger ribonucleic acid in the rat. Endocrinology 1993; 133: 2561-7.
42. 42. Kaupmann K, Bruns C, Hoyer D, Seuwen K, Lubbert H. Distribution and second messenger coupling of four somatostatin receptor subtypes expressed in brain. FEBS Lett 1993; 331: 53-9.
43. 43. Wulfsen I, Meyerhof W, Fehr S, Richter D. Expression patterns of rat somatostatin receptor genes in pre-and post-natal brain and pituitary. J Neurochem 1993; 61: 1549-52.
44. 44. Bito H, Mori M, Sakanada C, Takano T, Honda Z, Gotoh Y, Nishida E, Shimizu T. Functional decoupling of SSTR4, a major hippocampal somatostatin receptor, to adenylate cyclase inhibition, arachidonic acid release, and mitogen activated protein kinase cascade. J Biol Chem 1994; 269: 12722-30.
45. 45. Dorflinger LJ, Schonbrunn A. Somatostatin inhibits VIP-stimulated cAMP accumulation in GH pituitary cells. Endocrinology 1983; 113: 1541-58.
46. 46. Koch BD, Schonbrunn A. The somatostatin receptor is directly coupled to adenylate cyclase in GH4C1 pituitary cell membrane. Endocrinology 1984; 114: 1784-90.
47. 47. Schettini G, Florio T, Meucci O, Landolfi E, Lombardi G, Marino A. Somatostatin inhibition of anterior pituitary adenylate cyclase activity: different sensitivity between male and female rats. Brain Res 1988; 439: 322-9.
48. 48. Schettini G, Florio T, Meucci O, Landolfi E, Grimaldi M, Ventra C, Marino A. Somatostatin inhibition of adenylate cyclase activity in different brain areas. Brain Res 1989; 492: 65-71.
49. 49. Cronin MJ, Rogol AD, Meyers GA, Hewlett EL. Pertussis toxin blocks the SRIF induced inhibition of GH release and adenosine 3′,5′-monophosphate accumulation. Endocrinology 1983; 113: 209-15.
50. 50. Hershberger RE, Newman BL, Florio T, Bunzow J, Civelli O, Li XJ, Forte M, Stork PJS. The somatostatin receptors SSTR1 and SSTR2 are coupled to inhibition of adenylyl cyclase activity in CHO cells via pertussis toxin sensitive pathways. Endocrinology 1994; 134: 1277-85.
51. 51. Hadcock JR, Strnad J, Eppler M. Rat somatostatin receptor type 1 couples to G proteins and inhibition of cyclic AMP accumulation. Mol Pharmac 1994; 45: 410-16.
52. 52. Hou C, Gilbert RL, Barber DL. Subtype specific signalling mechanisms of somatostatin receptors SSTR1 and SSTR2. J Biol Chem 1994; 269: 10357-62.
53. 53. Strnad J, Eppler MC, Corbett M, Hadcock JR. The rat SSTR2 somatostatin receptor subtype is coupled to inhibition of cAMP accumulation. Biochem Biophys Res Commun 1993; 191: 968-76.
54. 54. Vanetti M, Vogt G, Hollt V. The two isoforms of the mouse somatostatin receptor (mSSTR2A and mSSTR2B) differ in coupling efficiency to adenylate cyclase and in agonist-induced receptor desensitization. FEBS Lett 1993; 331: 260-6.
55. 55. Mayor F, Benovic J, Caron M, Lefkovitz F. Somatostatin induces translocation of the beta-adrenergic receptor kinase and desensitizes somatostatin receptors in S49 lymphoma cells. J Biol Chem 1987; 262: 6468-71.
56. 56. Law SF, Woulfe D, Reisine T. Somatostatin receptor activation of cellular effector systems. Cell Signal 1995; 7: 1-8.
57. 57. Law SF, Zaina S, Sweet R, Yasuda K, Bell G, Stadel J, Reisine T. Gi alpha 1 selectively couples somatostatin receptors subtype 3 to adenylyl cyclase: identification of the functional domains of this alpha subunit necessary for mediating the inhibition by somatostatin of cAMP formation. Molec Pharmacol 1994; 45: 587-90.
58. 58. Guild S, Itoh J, Kebabian J, Luini A, Reisine T. Forskolin enhances basal and potassium evoked hormone release from normal and malignant pituitary tissue: role of calcium. Endocrinology 1986; 118: 268-79.
59. 59. Luini A, Lewis D, Guild S, Schofield G, Wright F. Somatostatin, an inhibitor of ACTH secretion, decreases cytosolic free calcium and voltage-dependent calcium current in a pituitary cell line. J Neurosci 1986; 6: 3128-32.
60. 60. Ikeda SR, Schofield G. Somatostatin blocks a calcium current in rat sympathetic ganglion neurones. J Physiol 1989; 409: 221-40.
61. 61. Kleuss C, Heschler J, Ewel C, Rosenthal W, Schultz G. Wittig B. Assignment of G protein subtypes to specific receptors inducing inhibition of calcium currents. Nature 1991; 353: 43-8.
62. 62. Kleuss C, Scherubl H, Hescheler J, Schultz G, Witig B. Selectivity in signal transduction determined by γ subunits of heterodimeric G proteins. Science 1993; 259: 832-4.
63. 63. Kleuss C, Scherubl H, Hescheler J, Schultz G, Witig B. Different β-subunits determine G-protein interaction with transmembrane receptors. Nature 1992; 358: 424-6.
64. 64. Reisine T. Cellular mechanisms of somatostatin inhibition of calcium influx in the anterior pituitary cell line AtT20. J Pharmacol Exp Ther 1990; 254: 646-51.
65. 65. Wang HL, Reisine T, Dichter M. Somatostatin 14 and somatostatin 28 inhibit calcium current in rat neocortical neurons. Neuroscience 1990; 38: 335-42.
66. 66. Meriney SD, Gray B, Pilar GR. Somatostatin-induced inhibition of neuronal calcium current modulated by cGMP dependent protein kinase. Nature 1994; 369: 336-9.
67. 67. Fujii Y, Gonoi T, Yamada Y, Chihara K, Inagaki N, Seino S. Somatostatin receptor subtype SSTR2 mediates the inhibition of high voltage activated calcium channels by somatostatin and its analogue SMS 201-995. FEBS Lett 1994; 355: 117-20.
68. 68. Reisine T, Tallent M, Dichter M. Somatostatin receptor subtypes endogenously expressed in AtT20 cells couple to three different ionic currents. 20th Soc Neurosci Meet 1994; abs. 376.19.
69. 69. Watson TWJ, Pittman QJ. Somatostatin(14) and -(28) but not somatostatin (1-12) hyperpolarize CA1 pyramidal neurons in vitro. Brain Res 1988; 448: 40-5.
70. 70. Mihara S, North RA, Suprenatant A. Somatostatin increases an inwardly rectifying potassium conductance in guinea pig submucosus plexus neurones. J Physiol 1987; 390: 335-55.
71. 71. Inoue M, Nakajima S, Nakajima Y. Somatostatin induces an inward rectification in rat locus coerulus neurones through a pertussis toxin-sensitive mechanism. J Physiol 1988; 407: 177-98.
72. M, a non-activating voltage dependent outward current blocked by muscarinic agonists. Proc Natl Acad Sci USA 1988; 85: 948-52.
73. 73. Wang HL, Bogen C, Reisine T, Dichter M. Somatostatin 14 and somatostatin 28 induce opposite effects on potassium currents in rat neocortical cultures. Proc Natl Acad Sci USA 1990; 86: 9616-20.
74. 74. Wang HL, Dichter M, Reisine T. Lack of cross-desensitization of somatostatin 14 and somatostatin 28 receptors coupled to potassium channels in rat neocortical neurons. Mol Pharmacol 1990; 38: 357-61.
75. 75. Meucci O, Landolfi E, Scorziello A, Grimaldi M, Ventra C, Florio T, Avallone A, Schettini G. Dopamine and somatostatin inhibition of prolactin secretion from MMQ pituitary cells: role of ATP-sensitive potassium channels. Endocrinology 1992; 131: 1942-7.
76. + channels by isolated Gk protein in clonal rat anterior pituitary cell membranes. Mol Endocrinol 1987; 1: 283-93.
77. 77. Liebow C, Reilly C, Serrano M, Shally AV. Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase. Proc Natl Acad Sci USA 1989; 86: 2003-7.
78. 78. Brevini TA, Bianchi R, Motta M. Direct inhibitory effect of somatostatin on the growth of the human prostatic cancer cell line LNCaP: possible mechanism of action. J Clin Endocrinol Metab 1993; 77: 626-31.
79. 79. Hierowski MT, Liebow C, du Sapin K, Schally AV. Stimulation by somatostatin of dephosphorylation of membrane proteins in pancreatic cancer MIA PaCa2 cell line. FEBS Lett 1985; 179: 252-6.
80. 80. Lee MT, Liebow C, Kamer AR, Shally AV. Effects of epidermal growth factor and analogues on luteinizing hormone-releasing hormone and somatostatin on phosphorylation and dephosphorylation of tyrosine residues of specific protein substrates in various tumors. Proc Natl Acad Sci USA 1991; 88: 1656-60.
81. 81. Pan MG, Florio T, Stork PJS. G protein activation of a hormone stimulated protein tyrosine phosphatase in human tumor cells. Science 1992; 256: 1215-7.
82. 82. Buscail L, Delesque N, Esteve JP, Saint-Laurent N, Prats H, Clerc P, Robberecht P, Bell GI, Liebow C, Schally AV, Vaysse N, Susini C. Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2. Proc Natl Acad Sci USA 1994; 91: 2315-9.
83. 83. Buscail L, Esteve JP, Sain-Laurent N, Bertrand V, Reisine T, O'Carrol AM, Bell GI, Schally AV, Vayasse N, Susini C. Inhibition of cell proliferation by somatostatin analogue RC160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms. Proc Natl Acad Sci USA 1995; 92: 1580-4.
84. 84. Colas B, Cambillau C, Buscail L, Zeggari M, Esteve JP, Lautre V, Thomas F, Vaysse N, Susini C. Stimulation of a membrane tyrosine phosphatase activity by somatostatin analogues in rat pancreatic acinar cells. Eur J Biochem 1992; 207: 1017-24.
85. 85. Zeggari M, Esteve JP, Rauly I, Cambillau C, Mazarguil H, Dufresne M, Pradayrol L, Chayvialle JA, Vaysse N, Susini C. Co-purification of a protein tyrosine phosphatase with activated somatostatin receptors from rat pancreatic acinar membranes. Biochem J 1994; 303: 441-8.
86. 86. Florio T, Pan MG, Newman B, Hershberger RE, Civelli O, Stork PJS. Dopaminergic inhibition of DNA synthesis in primary tumor cells is associated with phosphotyrosine phosphatase activity. J Biol Chem 1992; 267: 24169-72.
87. 87. Freiss G, Vignon F. Antiestrogens increased protein tyrosine phosphatase activity in human breast cancer cells. Molec Endocrin 1994; 8: 1389-96.
88. 88. Cook LL, Faux GA, Knight DL, Bissette G, Nemeroff CB. Assessment of somatostatin-acetyl choline interactions in the rat cerebral cortex. 19th Meeting Soc Neurosci 1998 abs 394.16.
89. ++ mobilization by cloned human somatostatin receptor subtypes 1-5 in transfected COS-7 cells. FEBS Lett 1994; 348: 192-6.
90. 90. Richardson SB, Laya T, Gibson M, Eyler N, Van Ooy M. Somatostatin inhibits vasopressin-stimulated phosphoinositide hydrolysis and influx of extracellular calcium in clonal hamster beta (HIT) cells. Biochem J 1992; 288: 847-85.
91. 91. Vallar L, Muca C, Magni M, Albert P, Bunzow J, Meldolesi J, Civelli O. Differential coupling of dopaminergic D2 receptors expressed in differential cell types. J Biol Chem 1990; 265: 10320-6.
92. 92. Sakanaka C, Ferby I, Waga I, Bito H, Shimizu T. On the mechanism of cytosolic phospholipase A2 activation in CHO cells carrying somatostatin receptors: wortmannin-sensitive pathway to activate mitogen-activated protein kinase. Biochem Biophys Res Commun 1994; 205: 18-23.
93. 93. White RE, Schonbrunn A, Armstrong DL. Somatostatin stimulates calcium activated potassium channels through protein dephosphorylation. Nature 1991; 351: 570-3.
94. 94. Barber DL, McGuire ME, Ganz MB. β-adrenergic and somatostatin receptors regulate Na-H exchange independent of cAMP. J Biol Chem 1989; 264: 21038-42.